Table 2.

Univariate cox proportional hazard analysis to identify significant predictors for all-cause mortality.

Variable	Hazard ratio	95%CI	p-Value
Clinical/angiographic variables
Age	1.05	1.02–1.09	0.001
Male	1.78	0.68–4.66	0.243
BMI	1.05	1.03–1.09	0.038
Smoking	1.96	0.93–4.13	0.074
Hypertension	1.76	0.86–3.63	0.124
Dyslipidemia	1.13	0.52–2.22	0.734
Diabetes	2.90	1.38–6.06	0.005
Chronic kidney disease	6.59	3.13–13.89	<0.001
Stroke/TIA	1.54	0.88–4.12	0.212
Post-PCI TIMI flow	1.43	0.64–3.12	0.332
No of diseased vessels	2.08	1.40–3.10	<0.001
Infarct type (STEMI)	1.53	0.62–3.75	0.347
LV and RV size and function
LVEF	0.96	0.92–0.99	0.030
LVEDVi	1.03	1.01–1.05	0.009
LVESVi	1.02	0.99–1.02	0.611
LVMI	1.77	1.06–2.71	0.049
RV S′	1.04	0.90–1.12	0.938
Guideline recommended diastolic parameters
E/A > 2	1.36	0.17–10.0	0.759
Average E/e′ > 14	3.41	1.59–7.28	0.002
TR Velocity > 2.8 m/s	1.76	0.92–3.14	0.155
LAVI >34 ml/m2	3.22	1.57–6.67	0.001
Significant (grade 2/3) DD	3.97	1.86–8.47	<0.001
Discharge medications
Aspirin	0.74	0.22–3.12	0.718
Beta-blocker	1.04	0.61–2.19	0.927
ACE-inhibitor/ARB blocker	0.55	0.25–1.25	0.076
Statin	0.90	0.24–3.23	0.562
Dual antiplatelet therapy	0.54	0.29–0.99	0.049

MACE = major adverse cardiovascular events; BMI = body mass index; STEMI = ST elevation MI; BMI = body mass index; LV = left ventricular; LVEF = left ventricular ejection fraction; LVEDVi = left ventricular end diastolic volume index; LVESVi = left ventricular end systolic volume index; E/A = ratio of mitral E wave to A wave; E/e′ = ratio of mitral E wave to e′; TR = tricuspid regurgitation; LAVI = left atrial volume index; DD2016 = diastolic dysfunction by 2016 guidelines; DD2009 = diastolic dysfunction by 2009 guidelines.